| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/14/1996 | US5516631 Method of inhibiting replication of hyperproliferative cells |
| 05/09/1996 | WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 05/09/1996 | WO1996013599A1 Nucleic acid transfer system |
| 05/09/1996 | WO1996013598A2 Hybrid adenovirus-aav virus and method of use thereof |
| 05/09/1996 | WO1996013597A2 Improved adenovirus and methods of use thereof |
| 05/09/1996 | WO1996013596A1 Viable contaminant particle free adenoviruses, their preparation and use |
| 05/09/1996 | WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 05/09/1996 | WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances |
| 05/09/1996 | WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 05/09/1996 | WO1996013276A1 Ocular gene therapy |
| 05/09/1996 | WO1996013269A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 05/09/1996 | WO1996007734A3 Recombinant adenovirus comprising a chimeric penton base protein |
| 05/09/1996 | CA2204020A1 Nucleic acid transfer system |
| 05/09/1996 | CA2203827A1 Novel family of protease inhibitors, and other biologic active substances |
| 05/09/1996 | CA2203641A1 Bcl-x/bcl-2 associated cell death regulator |
| 05/09/1996 | CA2203374A1 Ocular gene therapy |
| 05/09/1996 | CA2202881A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 05/08/1996 | EP0710722A1 Genetic mechanisms of tumor suppression |
| 05/08/1996 | EP0710288A1 Adenoviral vectors for treatment of hemophilia |
| 05/08/1996 | EP0710280A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 05/08/1996 | EP0710279A1 Yolk sac stem cells and their uses |
| 05/08/1996 | EP0710248A1 Melanoma-inhibiting protein |
| 05/08/1996 | EP0710123A1 Adenovirus vectors for gene therapy sponsorship |
| 05/08/1996 | EP0667791A4 Isolation, growth, differentiation and genetic engineering of human muscle cells. |
| 05/07/1996 | US5514788 Oligonucleotide modulation of cell adhesion |
| 05/07/1996 | US5514786 Compositions for inhibiting RNA activity |
| 05/02/1996 | WO1996012811A2 Yeast telomerase components and methods using them |
| 05/02/1996 | WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same |
| 05/02/1996 | WO1996012807A2 Hepatitis e virus antigens and uses therefor |
| 05/02/1996 | WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 05/02/1996 | WO1996012791A1 Human abh |
| 05/02/1996 | WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | WO1996012508A2 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 05/02/1996 | WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 05/02/1996 | WO1996012406A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
| 05/02/1996 | WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/02/1996 | CA2202891A1 Composition use of nucleoside analogues and gene transfection for tissue imaging and thereapy |
| 05/02/1996 | CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
| 05/01/1996 | EP0709710A1 Electro-optic modulator with transverse electrical configuration and method of manufacture thereof |
| 05/01/1996 | EP0708671A1 Drug delivery |
| 05/01/1996 | EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors |
| 05/01/1996 | EP0708637A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 04/30/1996 | US5512438 Inhibiting RNA expression by forming a pseudo-half-knot RNA at the target's |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012030A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012006A2 Flow through electroporation apparatus and method |
| 04/25/1996 | WO1996011713A1 Genetic material containing composition |
| 04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | CA2202529A1 Gene-containing compositions |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2201399A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011276A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0619838A4 Repopulation of testicular seminiferous tubules with foreign cells. |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010641A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010555A1 Cationic transport reagents |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010400A1 Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
| 04/11/1996 | WO1996010390A1 Novel compositions for the introduction of polyanionic materials into cells |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705902A1 17q-Linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705336A1 Test and model for polycystic ovary syndrome and male pattern baldness |
| 04/10/1996 | EP0705335A1 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 04/10/1996 | EP0705334A1 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 04/10/1996 | EP0705270A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 04/09/1996 | US5506212 Oligonucleotides with substantially chirally pure phosphorothioate linkages |
| 04/09/1996 | US5506133 Polypeptide |
| 04/04/1996 | WO1996020276A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |